To Investigate the Real-world Efficacy and Safety of Sacituzumab Govitecan for HER2 Negative Metastatic Breast Cancer Patients in China.

Abroad (travel likely)Recruiting

Conditions

Breast Cancer Metastatic

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Contact: Study coordinator (Chaoqun Fei) · feicq@zjcc.org.cn · 0571-88123728

Study leads

Xiaojia Wang, MD; Ph.D
Principal Investigator
Zhejiang Cancer Hospital
Qin Wu, Ph.D
Principal Investigator
Hangzhou Institute of Medicine (HIM)
Huanhuan Zhou, MD
Principal Investigator
Zhejiang Cancer Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

Oligometastatic Breast Carcinoma · Breast Cancer · Metastatic Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Basking Ridge, United States · Middletown, United States

Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer.

Breast Cancer

Abroad (travel likely)RecruitingPHASE2

La Jolla, United States

HER2-PET Imaging in HER2-low Breast Cancers

Breast Cancer Metastatic

Abroad (travel likely)RecruitingPHASE1, PHASE2

Sherbrooke, Canada

Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer

Breast Cancer · HER2-positive Breast Cancer · Triple Negative Breast Cancer

Abroad (travel likely)Recruiting

Boston, United States